Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Nautilus Biotechnology, Inc. market cap for the quarter ending 2026-07-24 was $215.06M, a 122.17% increase year-over-year.
Nautilus Biotechnology, Inc. market cap for the quarter ending 2026-06-30 was $235.37M, a 148.76% increase year-over-year.
Nautilus Biotechnology, Inc. market cap for the quarter ending 2026-04-23 was $329.13M, a 265.93% increase year-over-year.
Nautilus Biotechnology, Inc. market cap for the quarter ending 2026-03-31 was $492.4M, a 353.35% increase year-over-year.
Nautilus Biotechnology, Inc. market cap for fiscal 2026 was $215.06M.
Nautilus Biotechnology, Inc. market cap for fiscal 2025 was $245.35M, a 15.81% increase from fiscal 2024.
Nautilus Biotechnology, Inc. market cap for fiscal 2024 was $211.86M, a 43.35% decline from fiscal 2023.
Nautilus Biotechnology, Inc. market cap for fiscal 2023 was $373.96M, a 66.38% increase from fiscal 2022.